About
Frank Gentile, Ph.D., is a biotech executive and investor-operator best known as Chief Executive Officer of Casma Therapeutics, where he became CEO in January 2023 after joining as COO in October 2018. Earlier, he was a Venture Partner at Third Rock Ventures and spent 12 years at Tekla Capital Management overseeing biotech and healthcare investments across public and private companies. His background also includes operating roles at Millennium Pharmaceuticals, Curis, Reprogenesis, and academic affiliation with Brown University.
Areas of interest
biotechautophagyrare diseaseneurodegenerationoncologycardiovascular diseaseinfectious diseasemedical devicesdiagnosticsdrug discovery